| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Dalal Anupam serves as a Director at WHWK. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $18.4M at current prices.
The biggest single holding is WHWK (~$18.4M) as Director. Net of sales, the recent Form 4 record there shows accumulation of 1,529,402 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 26, 2021 | WHWK Whitehawk Therapeutics, Inc. | Director | Buy | 1,529,402 | $13.08 | $19,999,989.95 | New | -30.6% | -60.0% |